Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Liquidia Corp Director's Dealing 2023

Apr 10, 2023

31694_dirs_2023-04-10_4cd66f9b-a9cb-4572-a7d4-c7e495a00cfa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2022-08-31

Reporting Person: JEFFS ROGER (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-31 Common Stock A 993 $4.9045 Acquired 116007 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 46595 Indirect
Common Stock 1541667 Indirect

Footnotes

F1: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.

F2: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.

F3: This amendment is being filed solely to add this footnote 3 and to correct the transaction code in box 3 above. These shares of common stock were acquired on August 31, 2022 through the Liquidia Corporation 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).